Cellyan Biotechnology Co., Ltd (HKPD)
$0.10-9.09%Close
SELLCRISIS · day 32
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1M
- Beta
- 2.23
- P/E (TTM)
- -4.81
- Short % float
- 2.09%
- Days to cover
- 1.0
- SI change
- -66.3%
- 1W
- +0.00%
- 1M
- -16.67%
- vs SPY 1W
- +0.14%
- vs SPY 1M
- -19.17%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 10
- GROWTH
- 37
- GARP
- 5
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC-9.3%
REV YoY-
ROE-13.5%
EPS YoY-
ROA-8.8%
GROSS10
OP-7
NET-8
[VALUATION]
P/E TTM-4.81
P/E FWD-
SECTOR PE20.34
INDUSTRY PE14.26
P/B0.39
P/FCF-
EV/EBITDA-2.38
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E13.13
ALTMAN Z-
CURR RATIO3.86
ND/EBITDA-
BETA2.23
NET INCOME (TTM) < 0
Company news
FAQ
- What is LOPJLB’s current signal on HKPD?
- LOPJLB’s latest quantitative signal on Cellyan Biotechnology Co., Ltd (HKPD) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is HKPD in?
- Cellyan Biotechnology Co., Ltd (HKPD) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Cellyan Biotechnology Co., Ltd (HKPD) do?
- Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical sup…